跳至主要内容
临床试验/NCT04250584
NCT04250584Unknown不适用

Investigation of the Substantial Equivalence of a Novel Mandibular Advancement Device, iSlpr™, With SomnoDent® Classic, in a Non-inferiority Study, in the Treatment of Snoring and Mild to Moderate Obstructive Sleep Apnoea.

BioAnalytics Holdings Pty Ltd0 个研究点目标入组 66 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
66
主要终点
AHI

研究概览

简要总结

The study is a thirty three week, prospective, open-label, randomized, parallel-group non-inferiority study.

The study aims to investigate the Substantial Equivalence of a novel mandibular device called iSlpr™, produced by BioAnalytics, to a currently approved device, SomnoDent® Classic, in the treatment of mild to moderate Obstructive Sleep Apnoea (OSA) and snoring.

详细描述

The objective of this study is to determine if the BioAnalytics device, iSlpr™, has a similar safety and efficacy profile to a commonly used device, SomnoDent® Classic, in the treatment of snoring and mild to moderate Obstructive Sleep Apnoea.

The target population will be males and females aged from 18 years to less than 75 years, who have been diagnosed with snoring and mild to moderate sleep apnoea.

Participants will remain on study from screening visit to end of study visit; a total of approximately 33 weeks.

This study includes -

  • a screening period of up to 28 days
  • a 2 week device initiation period
  • a 24 week treatment period

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older and younger than 75 years at time of screening
  • Snoring and mild to moderate sleep apnoea ( AHI > 5 and < 30 per hr)
  • Written informed consent
  • Able to complete the study procedures within the study timeline.

排除标准

  • Women who are pregnant or breast-feeding
  • Central sleep apnoea
  • Severe respiratory disorders
  • Loose teeth or advanced periodontal disease
  • Lateral bruxers
  • Full or partial dentures
  • Temporomandibular Joint (TMJ) abnormalities, pain or dysfunction
  • Other teeth, jaw or gum disorders would preclude use of the device
  • Cardiovascular comorbidities or stroke/heart attack in past 12 months
  • Drug-addiction
  • Major Depressive Disorder or psychosis
  • Undergoing concomitant therapy for OSA/Snoring
  • current or previous therapy with SomnoDent Classic
  • Professional drivers or machine operators required to be undertaking CPAP

结局指标

主要结局

AHI

时间窗: 24 weeks

Apnea Hypopnea Index

ODI

时间窗: 24 weeks

Oxygen Desaturation Index

次要结局

未报告次要终点

研究者

发起方
BioAnalytics Holdings Pty Ltd
申办方类型
Industry
责任方
Sponsor

相似试验

Substantial Equivalence of iSlpr™ and SomnoDent®... | 临床试验